An investigation of circulating and in situ lymphocyte subsets and Langerhans cells in the skin and cervix of patients with chronic renal failure

Abstract

This study was designed to detect possible changes in the immunocytology of the human immune system in the skin, cervix and peripheral blood of patients with chronic renal failure (CRF) treated by conservative methods, haemodialysis (HD) and continuous ambulatory peritoneal dialysis (CAPD). In the skin, Langerhans cell numbers were reduced in CRF, CAPD and HD patients but in the cervix, Langerhans cells were reduced only in the CRF patients. There was a preponderance of T suppressor lymphocytes compared with T helper lymphocytes in the epidermis in the CRF and the CAPD groups. The presence of natural killer cells in the epidermis of the renal groups compared to controls was significant in the CRF and HD patients while the presence of T suppressor lymphocytes in the epidermis compared to controls was significant only in the CAPD patients. In the dermis, there was a mixed cellular infiltrate of T helper and T suppressor lymphocytes but with no subset attaining significance. The dermal infiltrate of T helper lymphocytes in all three groups of renal patients was significantly reduced compared to controls. In CRF patients, peripheral blood pan T cells, T helper and T suppressor lymphocytes and B lymphocytes were reduced, while T suppressor lymphocytes were reduced in both HD and CAPD patients, compared to controls. Though the results confirm alteration of the immunocytology of the skin, cervix and peripheral blood, we could not relate them to a clinical finding.

Characteristic Cytokine Products of Th1 and Th2 Cells in Hemodialysis Patients

“…We found that the cells involved in the humoral axis of immunity were consistent with those of reported studies [15, 24, 27, 28], providing evidence of a low proportion of B cells in HD patients. This could partly account for the altered antibody response in uremia.…”

Nail disorders in hemodialysis patients and renal transplant recipients: a case-control study

“…19,20 We found that onychomycosis was the second most frequent (19.2%) nail disorder in our hemodialysis patient group. In two previous reports on these patients, the rates of onychomycosis were 6.2% 3 and 52%.…”

Peripheral blood dendritic cells and GM-CSF as an adjuvantfor hepatitis B vaccination in hemodialysis patients

“…Direct evidence for this hypothesis is lacking, and only in mice it has been shown that GM-CSF administration increases the number of splenic dendritic cells, especially DC1 [27,28]. In hemodialysis patients a relative paucity of dendritic cells in the skin has been observed [29,30].…”